- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (32)
4 result(s) found for: RPR.
Displaying page 1 of 1.
| EudraCT Number: 2014-003969-24 | Sponsor Protocol Number: EstudioDOLBEN | Start Date*: 2014-09-18 | |||||||||||
| Sponsor Name:Vicente Estrada Pérez | |||||||||||||
| Full Title: Randomized clinical trial to analysis of pain after administration intramuscular benzathine penicillin needle gauge and length greater local anesthetic or not, in the administration with a traditio... | |||||||||||||
| Medical condition: Pain due to intramuscular injection in syphilis. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-002446-21 | Sponsor Protocol Number: ARTROCELL | Start Date*: 2020-04-20 | |||||||||||
| Sponsor Name:IBSAL (Instituto de Investigación Biomédica de Salamanca) | |||||||||||||
| Full Title: Phase III, multicentre, randomized, open clinical trial comparing treatment with allogenic mesenchymal cells against autologous mesenchymal cells and against active control with hyaluronic acid in ... | |||||||||||||
| Medical condition: Knee osteoarthritis | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2006-000604-16 | Sponsor Protocol Number: ARD6772 | Start Date*: 2006-08-30 |
| Sponsor Name:sanofi-aventis recherche & développement | ||
| Full Title: A Multicenter, Open-Label, Single-Arm Study of Intravenous AVE0005 (VEGF Trap) Administered Every 2 Weeks in Advanced Ovarian Cancer Patients with Recurrent Symptomatic Malignant Ascites. | ||
| Medical condition: Advanced ovarian cancer patients with recurrent symptomatic malignant ascites. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: SE (Completed) IT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-003166-39 | Sponsor Protocol Number: ChImDLP-2 | Start Date*: 2022-08-08 | |||||||||||
| Sponsor Name:UAB Froceth | |||||||||||||
| Full Title: A study of the safety of chemoimmunotherapy with autologous Dendritic Cell Preparations in patients with stage III ovarian cancer | |||||||||||||
| Medical condition: Stage III of high malignancy Ovarian serous adenocarcinoma | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Female | ||||||||||||
| Trial protocol: LT (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.